The peanut butter recall 2009 demonstrates that even peanut butter is no longer safe for indiscriminate human consumption. Of course, with warnings against Prenatal Rx tablets making less news than King Nut, the question is posed if you are up to date on the recalled items on your shelves and in your medicine cabinet.
Peanut Butter Recall
The Seattle Times reports that King Nut of Ohio is recalling two lines of peanut butter – King Nut and Parnell’s Pride – because of their potential links to a salmonella outbreak. US Recall News advises that the peanut butter recall 2009 involves products manufactured by the Peanut Corporation of America, but thus far is limited to only the two products indicated, not other peanut butter containing products sold under the King Nut name.
It appears that California is the current hotbed for salmonella cases related to this peanut butter recall. Thus far 55 cases have been confirmed. Nationwide, there are 399 cases of consumers who showed symptoms related to salmonella.
Peanut Corporation of America Expresses Concern
Although expressing its concerns about the salmonella found in a jar of its peanut butter, the Peanut Corporation of America goes on record that there is a “possibility of cross contamination from another source,” since the King Nut peanut butter was served at a nursing facility. Moreover, the company wants consumers to know that this product is used predominantly in institutions – the military, schools and nursing facilities – and is not a peanut butter that is available to the retail consumer.
Overall, it is evident that the manufacturer, distributor, and also the U.S. Food and Drug Administration are working together to get to the bottom of the salmonella outbreak.
A Tale of Two Manufacturers: Actavis Totowa, LLC
Unlike the manufacturer associated with the peanut butter recall 2009, the drug manufacturer Actavis Totowa, LLC was compelled to cooperate with the federal government by a consent decree. The FDA released a listing of 2009 new drugs that are not approved and yet manufactured by Actavis. Among them are Prenatal Rx tablets.
The FDA issued a 01-09-09 press release that warns the public about Actavis Totowa, LLC’s drugs which were “adulterated, misbranded and unapproved new drugs.” Actavis is a lot more positive about the situation and issued a press release that highlights the implementation of FDA required changes and also the institution of a new management team that will oversee the manufacture of its generic drugs in the future.
Sources: http://seattletimes.nwsource.com/html/nationworld/2008617165_newsline12.html; http://www.usrecallnews.com/2009/01/fda-3122.html; http://www.peanutcorp.com/pdf/PCA%20Press%20Release.pdf; http://www.fda.gov/bbs/topics/news/2009/actavis.html; http://www.fda.gov/bbs/topics/NEWS/2009/NEW01940.html; http://www.actavis.us/en/media+center/newsroom/articles/actavis+totowa+fda+agreement+consent+decree.htm